Certificate Number

GMPC or Non Compliance

Site Name

Site Address

City

Postcode

Country

Total Records 1091 to 1100 of 1631
Download
GMP Search Results
Certificate Number GMPC or Non-compliance Site Details Country Inspection Date
UK GMP 20689 Insp GMP 20689/13803-0006[H] GMPC

RECKITT BENCKISER HEALTHCARE MANUFACTURING (THAILAND) LIMITED, 65 MOO 12, LARDKRABANG-BANGPLEE ROAD, BANGPLEE, SAMUTPRAKARN, TH-10540, THAILAND

THAILAND
UK MIA(IMP) 12893 Insp GMP/IMP 12893/117868-0017[I] GMPC

UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST, BRISTOL ROYAL INFIRMARY, MARLBOROUGH STREET, BRISTOL, BS2 8HW, UNITED KINGDOM

UNITED KINGDOM
UK GMP 35697 Insp GMP 35697/1113679-0008[H] GMPC

SHARON BIO-MEDICINE LIMITED, CENTRAL HOPE TOWN, SELAQUI INDUSTRIAL AREA, DEHRADUN, UTTARAKHAND, IN-248 001, INDIA

INDIA
UK MIA 15929 Insp GMP 15929/9419881-0004[H] GMPC

AIR LIQUIDE - WOLVERHAMPTON, GAILEY PARK, GRAVELLY WAY, STANDEFORD, WOLVERHAMPTON, WV10 7GW, UNITED KINGDOM

UNITED KINGDOM
UK GMP 18058 Insp GMP 18058/10367-0012[H] GMPC

BAXTER PHARMACEUTICAL SOLUTIONS LLC, 927 SOUTH CURRY PIKE, BLOOMINGTON, 47403, UNITED STATES

UNITED STATES
UK MIA(IMP) 11149 Insp GMP/IMP 11149/104676-0026[I] GMPC

ROYAL FREE LONDON NHS FOUNDATION TRUST, PHARMACY DEPARTMENT, THE ROYAL FREE HOSPITAL, POND STREET, LONDON, NW3 2QG, UNITED KINGDOM

UNITED KINGDOM
UK GMP 20656 Insp GMP 33168/460035-0005[H] GMPC

CATALENT PHARMA SOLUTIONS LLC, 2725 SCHERER DRIVE NORTH, ST PETERSBURG, 33716, UNITED STATES

UNITED STATES
UK MIA(IMP) 30013 Insp GMP/IMP 30013/311656-0007[I] GMPC

PHARMARON BIOLOGICS (UK) LTD, NATIONAL BIOMANUFACTURING CENTRE, ESTUARY BANKS, ESTUARY COMMERCE PARK, SPEKE ROAD, LIVERPOOL, L24 8RB, UNITED KINGDOM

UNITED KINGDOM
UK GMP 25041 Insp GMP 25041/16593191-0001[H] GMPC

REGENERON PHARMACEUTICALS INCORPORATED, 26 TECH VALLEY DRIVE, EAST GREENBUSH, 12061, UNITED STATES

UNITED STATES
UK GMP 13509 Insp GMP 13509/4002-0014[H] GMPC

ANDERSONBRECON INCORPORATED, 4545 ASSEMBLY DRIVE, ROCKFORD, 61109, UNITED STATES

UNITED STATES

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX